No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Trending Stocks in Bearish Pre-holiday Week for U.S. Stock Market
Sarepta Awarded $115.2M in Vyondys 53 Patent Case: Report
Vertex Announces U.S. FDA Approval For TRIKAFTA To Include Additional Non-F508del TRIKAFTA-Responsive Variants
BMO Capital Maintains Outperform on Vertex Pharmaceuticals, Lowers Price Target to $520
J.P. Morgan's Top Healthcare Stocks for 2025
Needham Reiterates Hold on Neurocrine Biosciencesto Hold